1. Astragaloside IV, as a potential anticancer agent
   Dongqin Xia et al, 2023, Frontiers in Pharmacology CrossRef
2. Arene–Arene Coupled Disulfamethazines (or Sulfadiazine)-Phenanthroline-Metal(II) Complexes were Synthesized by In Situ Reactions and Inhibited the Growth and Development of Triple-Negative Breast Cancer through the Synergistic Effect of Antiangiogenesis, Anti-Inflammation, Pro-Apoptosis, and Cuproptosis
   Bing-Bing Xu et al, 2024, Journal of Medicinal Chemistry CrossRef
3. MicroRNA-181a is elevated by 10-hydroxycamptothecin and represses lung carcinoma progression by downregulating FOXP1
   LI PAN et al, 2022, BIOCELL CrossRef
4. Galectins: Important Regulators in Normal and Pathologic Pregnancies
   Min Chen et al, 2022, International Journal of Molecular Sciences CrossRef
5. Novel Drugs with High Efficacy against Tumor Angiogenesis
   Shiyu Qi et al, 2022, International Journal of Molecular Sciences CrossRef
6. Development of a prognostic model based on an immunogenomic landscape analysis of medulloblastoma
   Yuduo Guo et al, 2021, Bioscience Reports CrossRef
7. The application and research progress of anti-angiogenesis therapy in tumor immunotherapy
   Jingyao Tu et al, 2023, Frontiers in Immunology CrossRef
8. VEGF-Independent Angiogenic Factors: Beyond VEGF/VEGFR2 Signaling
   Ryoji Eguchi et al, 2022, Journal of Vascular Research CrossRef
9. The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients
   Longhai Li et al, 2021, Frontiers in Oncology CrossRef
10. Application of an angiogenesis-related genes risk model in lung adenocarcinoma prognosis and immunotherapy
    Jinsong Wang et al, 2023, Frontiers in Genetics CrossRef
11. Profiling Kinase Activities for Precision Oncology in Diffuse Gastric Cancer
    Smrita Singh et al, 2024, OMICS: A Journal of Integrative Biology CrossRef
12. Downregulated miR-150-5p in the Tissue of Nasopharyngeal Carcinoma
    Jia-Ying Wen et al, 2022, Genetics Research CrossRef
13. Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer
    Yongkang Ye et al, 2023, Disease Markers CrossRef